Tienilic Acid

CAS No. 40180-04-9

Tienilic Acid( Ticrynafen | ANP 3624 )

Catalog No. M28066 CAS No. 40180-04-9

Tienilic Acid is a uricosuric diuretic with certain hepatotoxicity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
5MG 37 In Stock
10MG 68 In Stock
25MG 140 In Stock
50MG 203 In Stock
100MG 300 In Stock
200MG 449 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tienilic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Tienilic Acid is a uricosuric diuretic with certain hepatotoxicity.
  • Description
    Tienilic Acid is a uricosuric diuretic with certain hepatotoxicity.(In Vivo):In female and male Sprague-Dawley rats, Tienilic Acid decreased blood pressure and serum uric acid at 30 mg/kg. Tienilic acid decreased slightly hemoglobin and increased S-GPT at 120 and 480 mg/kg. Tienilic Acid significantly increase the liver weight and serum magnesium concentration in male rats, while the liver weight of female rats increased only slightly. Tienilic Acid also induced unicellular necrosis of small groups of liver cells.
  • In Vitro
    ——
  • In Vivo
    Tienilic acid (100 mg/lg in rats and mice, 5 mg/kg in pigs and dog; PO and IV; single dosage) is only found in plasma, eliminates by the biliary and the urinary fast, and exhibits small differences in the different species.Tienilic acid (0-480 mg/kg; PO; for 28 days) decreases blood pressure, serum, uric acidhemoglobin, and increased S-GPT; induces unicellular necrosis of small groups of liver cells. Animal Model:Rats, mice, pigs and dogs Dosage:100 mg/lg in rats and mice, 5 mg/kg in pigs and dogs Administration:PO and IV; single dosageResult:Only found in plasma with important bindings to the plasma proteins at the blood level; pharmacological action for several hours; eliminated by the biliary and particularly the urinary fast, practically total in the first 48 hours after administration; only small differences were observed for the parameters measured in the different species.Animal Model:Female and male Sprague-Dawley rats Dosage:0, 30, 120 and 480 mg/kg Administration:PO; for 28 days Result:Decreased blood pressure and serum uric acid at 30 mg/kg; decreased slightly hemoglobin and increased S-GPT at 120 and 480 mg/kg; significantly increase the liver weight and serum magnesium concentration in male rats, while the liver weight of female rats increased only slightly; besides, induced unicellular necrosis of small groups of liver cells.
  • Synonyms
    Ticrynafen | ANP 3624
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    40180-04-9
  • Formula Weight
    331.16
  • Molecular Formula
    C13H8Cl2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (301.96 mM)
  • SMILES
    OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chan FC, et al. 3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer. J Med Chem. 1996 Aug 16;39(17):3319-23.
molnova catalog
related products
  • 2,6-Dimethoxyquinone

    2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.

  • CDD3505

    CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.

  • CYP4A11/CYP4F2-IN-1

    CYP4A11/CYP4F2-IN-1 is a cytochrome P450 (CYP) 4A11 and CYP4F2 inhibitor, applicable for research on kidney, cardiovascular, and cerebrovascular diseases.